Packaging Mix-Up May Cause Excessive Urination

Apace Packaging is recalling 4000mg Acyclovir tablets that due to a packaging error may also include Torsemide.

Acyclovir Tablets
Acyclovir Tablets

A recent FDA MedWatch article reported an unfortunate recall in which a packaging error led to the wrong drug being mixed into blister packs. On February 13th Apace Packaging voluntarily recalled one lot of Acyclovir tablets, an antiviral drug used to treat shingles, genital herpes, and chickenpox. A missed dose of Acyclovir could lead to the reactivation of the virus being treated.

The recalled lot of 400mg tablets in UD blister cards could contain 20mg tablets of Torsemide, a prescription drug used to treat edema and hypertension. Accidental dosing of Torsemide could cause excessive urination as well as other undesirable symptoms including chest pain, diarrhea, and rectal bleeding. Apace notified distributors and customers of the packaging error via email and is arranging for the return of all recalled product.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO